TEVA - Teva- Pharmaceutical Industries Ltd. - ADR
Close
18.87
0.140 0.742%
Share volume: 10,069,878
Last Updated: Fri 30 Aug 2024 10:00:03 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$18.73
0.14
0.75%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-03 | 2023-02-10 | 2023-05-10 | 2023-08-02 | 2023-11-09 | 2024-02-12 | 2024-05-08 | 2024-07-31 | |
| Cash flow financing | -440.000 M | -711.000 M | -706.000 M | -55.000 M | -576.000 M | -576.000 M | -151.000 M | -966.000 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | 543.000 M | 973.000 M | -145.000 M | 324.000 M | 5.000 M | 1.184 B | -124.000 M | 103.000 M | |
| Net income | 56.000 M | -1.219 B | -205.000 M | -863.000 M | 80.000 M | 430.000 M | -139.000 M | -846.000 M | |
| Depreciation | 321.000 M | 306.000 M | 304.000 M | 300.000 M | 283.000 M | 266.000 M | 272.000 M | 259.000 M | |
| Changes in inventories | 3.859 B | 3.833 B | 4.118 B | 4.109 B | 4.051 B | 4.022 B | 3.949 B | 3.927 B | |
| Changes in receivables | 3.730 B | 3.696 B | 3.435 B | 3.539 B | 3.385 B | 3.408 B | 3.456 B | 3.766 B | |
| Investing Cashflow | 147.000 M | 168.000 M | 181.000 M | 302.000 M | 184.000 M | 301.000 M | 144.000 M | 178.000 M | |
| Net Borrowings | 17.417 B | 16.700 B | 16.753 B | 16.295 B | 16.037 B | 14.848 B | 14.822 B | 14.770 B | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -122.000 M | -142.000 M | -139.000 M | -119.000 M | -149.000 M | -119.000 M | -124.000 M | -97.000 M | |
| Cash Change | 2.225 B | 2.801 B | 2.143 B | 2.669 B | 2.249 B | 3.226 B | 2.991 B | 2.258 B |